Cumberland Pharmaceuticals Dirección
Dirección controles de criterios 3/4
El CEO de Cumberland Pharmaceuticals' es A. Kazimi , nombrado en Jan 1999, tiene una permanencia de 25.25 años. compensación anual total es $1.17M, compuesta por 57.7% salario y 42.3% primas, incluidas acciones y opciones de la empresa. posee directamente un 40.18% de las acciones de la empresa, por valor de $9.17M. La antigüedad media del equipo directivo y de la junta directiva es de 6.3 años y 10.9 años, respectivamente.
Información clave
A. Kazimi
Chief Executive Officer (CEO)
US$1.2m
Compensación total
| Porcentaje del salario del CEO | 57.7% |
| Permanencia del CEO | 25.3yrs |
| Participación del CEO | 40.2% |
| Permanencia media de la dirección | 6.4yrs |
| Promedio de permanencia en la Junta Directiva | 11yrs |
Actualizaciones recientes de la dirección
Recent updates
Is Cumberland Pharmaceuticals (NASDAQ:CPIX) Using Too Much Debt?
Mar 07
Cumberland Pharmaceuticals Inc.'s (NASDAQ:CPIX) Prospects Need A Boost To Lift Shares
Jan 09Why Investors Shouldn't Be Surprised By Cumberland Pharmaceuticals Inc.'s (NASDAQ:CPIX) Low P/S
Oct 02Is Cumberland Pharmaceuticals (NASDAQ:CPIX) Using Too Much Debt?
Aug 10Does Cumberland Pharmaceuticals (NASDAQ:CPIX) Have A Healthy Balance Sheet?
Mar 18Is Cumberland Pharmaceuticals (NASDAQ:CPIX) Using Too Much Debt?
Nov 02Calculating The Fair Value Of Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX)
Jul 20Is Cumberland Pharmaceuticals (NASDAQ:CPIX) Using Too Much Debt?
Apr 15Checking In On Cumberland Pharmaceuticals
Jan 04Health Check: How Prudently Does Cumberland Pharmaceuticals (NASDAQ:CPIX) Use Debt?
Nov 09We Think Some Shareholders May Hesitate To Increase Cumberland Pharmaceuticals Inc.'s (NASDAQ:CPIX) CEO Compensation
Apr 21Is Cumberland Pharmaceuticals (NASDAQ:CPIX) Using Debt In A Risky Way?
Feb 13One Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Analyst Just Cut Their EPS Forecasts
Nov 19
Cumberland Pharmaceuticals Inc. 2020 Q3 - Results - Earnings Call Presentation
Nov 11Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$8m |
| Dec 31 2023 | US$1m | US$675k | -US$6m |
| Sep 30 2023 | n/a | n/a | -US$2m |
| Jun 30 2023 | n/a | n/a | -US$2m |
| Mar 31 2023 | n/a | n/a | -US$4m |
| Dec 31 2022 | US$1m | US$635k | -US$6m |
| Sep 30 2022 | n/a | n/a | -US$7m |
| Jun 30 2022 | n/a | n/a | -US$9m |
| Mar 31 2022 | n/a | n/a | -US$7m |
| Dec 31 2021 | US$1m | US$610k | -US$6m |
| Sep 30 2021 | n/a | n/a | -US$3m |
| Jun 30 2021 | n/a | n/a | -US$3m |
| Mar 31 2021 | n/a | n/a | -US$5m |
| Dec 31 2020 | US$1m | US$590k | -US$7m |
| Sep 30 2020 | n/a | n/a | -US$8m |
| Jun 30 2020 | n/a | n/a | -US$10m |
| Mar 31 2020 | n/a | n/a | -US$10m |
| Dec 31 2019 | US$1m | US$567k | -US$9m |
| Sep 30 2019 | n/a | n/a | -US$8m |
| Jun 30 2019 | n/a | n/a | -US$6m |
| Mar 31 2019 | n/a | n/a | -US$6m |
| Dec 31 2018 | US$1m | US$545k | -US$11m |
| Sep 30 2018 | n/a | n/a | -US$6m |
| Jun 30 2018 | n/a | n/a | -US$5m |
| Mar 31 2018 | n/a | n/a | -US$9m |
| Dec 31 2017 | US$1m | US$523k | -US$8m |
Compensación vs. Mercado: La compensación total de A.($USD1.17M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD668.06K).
Compensación vs. Ingresos: La compensación de A. ha sido consistente con los resultados de la empresa en el último año.
CEO
A. Kazimi (65 yo)
25.3yrs
Permanencia
US$1,169,530
Compensación
Mr. A. J. Kazimi, MBA, founded Cumberland Pharmaceuticals Inc. in 1999 and has been its Chairman and Chief Executive Officer since 1999. Mr. Kazimi serves as the President of Cumberland Pharmaceuticals Inc...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Founder | 25.3yrs | US$1.17m | 40.18% $ 8.8m | |
| VP & CFO | 3yrs | US$282.32k | 0.18% $ 40.0k | |
| Executive VP of National Accounts & Chief Compliance Officer | 7.6yrs | US$400.15k | 0.27% $ 58.9k | |
| Vice President of Sales & Marketing | no data | US$316.29k | 0.033% $ 7.2k | |
| Vice President of Organizational Development | no data | US$330.85k | 0.12% $ 25.1k | |
| Senior VP of Administrative Services & Corporate Secretary | no data | US$298.01k | sin datos | |
| Managing Director | 5.3yrs | sin datos | sin datos | |
| Senior Corporate Relations Associate | no data | sin datos | sin datos |
6.4yrs
Permanencia media
65yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de CPIX es experimentado (6.3 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Founder | 25.3yrs | US$1.17m | 40.18% $ 8.8m | |
| Member of Pharmaceutical Advisory Board | no data | sin datos | sin datos | |
| Independent Director | 5.7yrs | US$61.20k | 0.42% $ 91.4k | |
| Member of Medical Advisory Board | no data | sin datos | sin datos | |
| Chairman of Medical Advisory Board & Independent Director | 14.3yrs | US$98.00k | sin datos | |
| Member of Pharmaceutical Advisory Board | no data | US$233.65k | sin datos | |
| Director | 1.8yrs | US$50.00k | 0.042% $ 9.2k | |
| Member of Medical Advisory Board | no data | sin datos | sin datos | |
| Member of Pharmaceutical Advisory Board | no data | sin datos | sin datos | |
| Member of Medical Advisory Board | no data | sin datos | sin datos | |
| Independent Director | 7.7yrs | US$61.20k | 0.19% $ 41.1k | |
| Independent Director | 14.3yrs | US$60.20k | sin datos |
11.0yrs
Permanencia media
71yo
Promedio de edad
Junta con experiencia: Los miembros de la junta directiva de CPIX son experimentados ( 10.9 años antigüedad media).